Pharmacokinetic study of pazufloxacin mesylate in Chinese healthy volunteers
Junxian Yu
Abstract
Junxian Yu
Abstract
OBJECTIVE To investigate the pharmacokinetics of pazufloxacin mesylate in Chinese healthy volunteers.METHODS Twelve healthy volunteers were received a single dose(300 mg),then multi-doses(300 mg bid)within 30 min intravenous infusion of pazufloxacin mesylate in an open randomized cross-over study.The plasma concentration of pazufloxacin were determined by HPLC-fluorescence.RESULTS The quantitation limit was 0.028 mg·L-1 The relative standard deviations for within-day and between-day were all 5%,And the recoveris were 90%.A good linearity was obtained from 0.028 to 14.50 mg·L-1.The results showed that the plasma concentration-time curve conformed to two compatment model.Pharmacokinetic profiles were fitted to an open two-compartment model analyzed by using 3P97.The mean pharmacokinetic parameters of singl dose and multi dose were:Cmax(7.2±0.8)mg·L-1 and(7.3±0.8)mg·L-1;t1/2(2.04±0.17)h and(2.24±0.23)h;AUC0-t(14.0±1.5)mg·h·L-1 and(13.1±1.5)mg·h·L-1;Vc(27.2±4.6)L and(25.3±8.8)L;CL(22.1±2.6)L·h-1 and(23.7±2.1)L·h-1,respectively.No significant diference existed between a single dose and multiple doses.but significant diffences of T1/2 and MRT occurred within man and fimale whether by a single dose or multiple doses.CONCLUSION Pazufloxacin mesylate is tolerant with a single dose or multi-doses.by intravenous infusion in Chinese healthy volunteers.No accumulation in the body was observed after 5 days administration.Significant diference in pharmacokinetic parameters such as t1/2 and MRT may be due to sex differenc.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To investigate the pharmacokinetics of pazufloxacin mesylate in Chinese healthy volunteers.METHODS Twelve healthy volunteers were received a single dose(300 mg),then multi-doses(300 mg bid)within 30 min intravenous infusion of pazufloxacin mesylate in an open randomized cross-over study.The plasma concentration of pazufloxacin were determined by HPLC-fluorescence.RESULTS The quantitation limit was 0.028 mg·L-1 The relative standard deviations for within-day and between-day were all 5%,And the recoveris were 90%.A good linearity was obtained from 0.028 to 14.50 mg·L-1.The results showed that the plasma concentration-time curve conformed to two compatment model.Pharmacokinetic profiles were fitted to an open two-compartment model analyzed by using 3P97.The mean pharmacokinetic parameters of singl dose and multi dose were:Cmax(7.2±0.8)mg·L-1 and(7.3±0.8)mg·L-1;t1/2(2.04±0.17)h and(2.24±0.23)h;AUC0-t(14.0±1.5)mg·h·L-1 and(13.1±1.5)mg·h·L-1;Vc(27.2±4.6)L and(25.3±8.8)L;CL(22.1±2.6)L·h-1 and(23.7±2.1)L·h-1,respectively.No significant diference existed between a single dose and multiple doses.but significant diffences of T1/2 and MRT occurred within man and fimale whether by a single dose or multiple doses.CONCLUSION Pazufloxacin mesylate is tolerant with a single dose or multi-doses.by intravenous infusion in Chinese healthy volunteers.No accumulation in the body was observed after 5 days administration.Significant diference in pharmacokinetic parameters such as t1/2 and MRT may be due to sex differenc.
Key concepts: Pharmacokinetics, Cmax, Pharmacology, Chemistry, Mesylate, Chromatography, Plasma concentration, Medicine